Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Thirteen Scholarships for Science and Mathematics learners awarded

2011-02-15

The Thirteen Scholarship winners are seen here with: Back: Mr Cobus van Breda (Project Manager, School for Continuing Education, far left), Prof. Jonathan Jansen (Vice-Chancellor and Rector of the UFS, Second from the right), Prof Dennis Francis (Dean of the Faculty of Education, on the right), Middle: Ms Elizna Prinsloo (School for Continuing Education, left) and Ms. Pearl Nhlane (SANRAL, right).
- Photo: Stephen Collet

Thirteen learners from the University of the Free State (UFS)’s School for Continuing Education (SCE) were successful in their applications for school scholarships at SANRAL (South African National Roads Agency). This represents more than a third of the successful applications countrywide.

The SCE’s ICT Laboratory aims to enable and encourage more learners to enter into science related studies and careers. To achieve this, 180 selected learners from Grade 10, 11 and 12 are exposed to activities at the ICT Laboratory every year. “It is an attempt not only to foster a positive attitude towards Mathematics and Science amongst learners, but also to raise their knowledge and skills levels through e-Education in Science and Mathematics,” says Mr Cobus van Breda, Project Manager of the programme.

As part of the programme, learners have the opportunity to apply for a scholarship at the sponsor, namely SANRAL (South African National Roads Agency). The scholarship not only covers all school and hostel fees for the particular year, but also includes stationary as well as school and sports outfits of the learner.

At a recent information session for successful learners and their parents held at the UFS, Ms Pearl Nhlane of SANRAL congratulated the learners and said that “SANRAL is recognising the hard work of the learners by investing in them”. Prof. Jonathan Jansen, Vice-Chancellor and Rector of the UFS, in turn thanked SANRAL for their initiative and told the learners “that one has to take the gap when one gets the opportunity”, indicating to the learners that the scholarship can be seen as such an opportunity, since it can possibly pave the way to study benefits in future.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept